These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 15917570)

  • 1. Caspofungin in combination with amphotericin B against Candida glabrata.
    Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of candidemia on caspofungin therapy: a case report.
    Cheung C; Guo Y; Gialanella P; Feldmesser M
    Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient].
    Rome A; André N; Michel A; Coze C; Gentet JC; Bernard JL
    Arch Pediatr; 2006 Dec; 13(12):1556-7. PubMed ID: 17049216
    [No Abstract]   [Full Text] [Related]  

  • 4. Caspofungin in combination with amphotericin B against Candida parapsilosis.
    Barchiesi F; Spreghini E; Tomassetti S; Giannini D; Scalise G
    Antimicrob Agents Chemother; 2007 Mar; 51(3):941-5. PubMed ID: 17158939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
    Mariné M; Serena C; Fernández-Torres B; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4757-9. PubMed ID: 16251323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of liposomal amphotericin B refractory Candida glabrata fungaemia in a patient undergoing a stem cell transplantation.
    Veldman BA; Verweij PE; Blijlevens NM
    Neth J Med; 2006 Apr; 64(4):127-9. PubMed ID: 16609161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of Candida krusei fungemia with amphotericin B and caspofungin.
    Olver WJ; Scott F; Shankland GS
    Med Mycol; 2006 Nov; 44(7):655-7. PubMed ID: 17071561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined antifungal therapy in a murine infection by Candida glabrata.
    Mariné M; Serena C; Pastor FJ; Guarro J
    J Antimicrob Chemother; 2006 Dec; 58(6):1295-8. PubMed ID: 17012301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
    Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient.
    Krogh-Madsen M; Arendrup MC; Heslet L; Knudsen JD
    Clin Infect Dis; 2006 Apr; 42(7):938-44. PubMed ID: 16511756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis.
    Gumbo T; Drusano GL; Liu W; Ma L; Deziel MR; Drusano MF; Louie A
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3695-700. PubMed ID: 16954319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B.
    Spreghini E; Maida CM; Milici ME; Scalise G; Barchiesi F
    Antimicrob Agents Chemother; 2008 Feb; 52(2):513-7. PubMed ID: 18056279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspofungin for refractory candidemia in neonates.
    Manzar S; Kamat M; Pyati S
    Pediatr Infect Dis J; 2006 Mar; 25(3):282-3. PubMed ID: 16511405
    [No Abstract]   [Full Text] [Related]  

  • 14. Caspofungin as treatment for Candida glabrata hip infection.
    Lejko-Zupanc T; Mozina E; Vrevc F
    Int J Antimicrob Agents; 2005 Mar; 25(3):273-4. PubMed ID: 15737527
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.
    Cleary JD; Garcia-Effron G; Chapman SW; Perlin DS
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2263-5. PubMed ID: 18378714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of caspofungin and amphotericin B for invasive candidiasis.
    Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
    N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida glabrata endophthalmitis treated successfully with caspofungin.
    Sarria JC; Bradley JC; Habash R; Mitchell KT; Kimbrough RC; Vidal AM
    Clin Infect Dis; 2005 Mar; 40(5):e46-8. PubMed ID: 15714407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal activity of caspofungin in combination with amphotericin B against Candida glabrata: comparison of disk diffusion, Etest, and time-kill methods.
    Kiraz N; Dag I; Yamac M; Kiremitci A; Kasifoglu N; Akgun Y
    Antimicrob Agents Chemother; 2009 Feb; 53(2):788-90. PubMed ID: 19029317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.
    Oliveira ER; Fothergill AW; Kirkpatrick WR; Coco BJ; Patterson TF; Redding SW
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3544-5. PubMed ID: 16048980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility.
    Cota J; Carden M; Graybill JR; Najvar LK; Burgess DS; Wiederhold NP
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3926-8. PubMed ID: 16940061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.